miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1. (Q39493576)

12 September 2017

miR-125b confers resistance of ovarian cancer cells to cisplatin by targeting pro-apoptotic Bcl-2 antagonist killer 1. (English)

1 reference

12 September 2017

0 references

1 reference

1 reference

Fanfei Kong

1

1 reference

12 September 2017

Chaoyang Sun

2

1 reference

12 September 2017

Zhongxian Wang

3

1 reference

12 September 2017

Lingfei Han

4

1 reference

12 September 2017

Danhui Weng

5

1 reference

12 September 2017

Yunping Lu

6

1 reference

12 September 2017

Gang Chen

7

1 reference

12 September 2017

7 August 2011

1 reference

Journal of Huazhong University of Science and Technology. Medical Sciences

12 September 2017

1 reference

12 September 2017

31

1 reference

12 September 2017

543-549

1 reference

12 September 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s11596-011-0487-z

12 September 2017

0 references

cites work

Biological characterization of ovarian cancer: prognostic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

Role of chemotherapy in the management of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

Ovarian cancer: strategies for overcoming resistance to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

The transcriptional landscape of the mammalian genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

miRNAs, cancer, and stem cell division

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

MicroRNAs: critical regulators of development, cellular physiology and malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

miR-15 and miR-16 induce apoptosis by targeting BCL2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

Role of microRNAs in drug-resistant ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

MicroRNA signatures in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

MicroRNAs in ovarian cancer biology and therapy resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

MicroRNA and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

Role of microRNA in anticancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

Dicer-dependent pathways regulate chondrocyte proliferation and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

Survival Benefits With Diverse Chemotherapy Regimens for Ovarian Cancer: Meta-analysis of Multiple Treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11596-011-0487-Z

Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21823019

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11596-011-0487-Z

1 reference

release_jq6evutfcjcixfgggsamo4e3o4

12 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jq6evutfcjcixfgggsamo4e3o4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference